Wang Globalnet Recalled 1,705 Frozen Oyster Halves Over Norovirus Risk (2025)
Oyster product potentially contaminated with Norovirus
613 recalls tagged with “poisoning risk”.
Oyster product potentially contaminated with Norovirus
CGMP Deviations: Presence of a nitrosamine, N-Nitroso Carvedilol I Impurity above the current Acceptable Intake Level.
CGMP Deviations: Presence of a nitrosamine, N-nitroso-metoprolol above the established Acceptable Daily Intake (ADI) level.
CGMP Deviations: Results for N-Nitroso Carvedilol Impurity-1 (NNCI) impurity observed to be above the FDA-recommended limit of NMT 4.0 ppm
CGMP Deviations: Results for N-Nitroso Carvedilol Impurity-1 (NNCI) impurity observed to be above the FDA-recommended limit of NMT 4.0 ppm
Unapproved Drug Claims and Misbranded.
Unapproved Drug Claims and Misbranded.
Enoxaparin Sodium Injection recall active as of 2025. Cardinal Health and Sandoz Inc. distributed the product in Kansas. Bags labeled 80 mg/0.8 mL contained 30 mg/0.3 mL doses. Health authorities urge immediate stop-use and guidance from providers.
Potential for spoilage due to yeast contamination.
B. Braun Medical Inc. recalls 23,100 0.9% Sodium Chloride Injection L 8000 containers nationwide. The recall cites lack of assurance of sterility and potential fluid leakage at a weld site. Stop using immediately and consult a healthcare provider.
Lack of Assurance of Sterility.
Contains undeclared wheat. The top label identifies the product as potato salad, but the unit contains pasta salad.
Lack of Assurance of Sterility.
Product contains undeclared wheat and soy.
Failed Impurities/Degradation Specifications: out of specification results for arsenic in the impurities tested.
Dietary supplement involved degradation of an ingredient. Product is sub-potent for Vitamin B12 not meeting label claims.